Geode Capital Management LLC Acquires 243,802 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Geode Capital Management LLC boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,756,727 shares of the medical equipment provider’s stock after acquiring an additional 243,802 shares during the quarter. Geode Capital Management LLC owned about 2.18% of Intuitive Surgical worth $4,039,200,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. M.E. Allison & CO. Inc. bought a new position in shares of Intuitive Surgical during the 4th quarter valued at approximately $449,000. Seilern Investment Management Ltd bought a new position in Intuitive Surgical during the fourth quarter valued at $82,517,000. Sycomore Asset Management raised its stake in shares of Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock valued at $9,214,000 after acquiring an additional 4,079 shares during the period. Exome Asset Management LLC lifted its holdings in shares of Intuitive Surgical by 16.8% in the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after acquiring an additional 1,069 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. boosted its stake in shares of Intuitive Surgical by 5.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after purchasing an additional 525 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Up 0.7 %

NASDAQ:ISRG opened at $495.27 on Tuesday. The firm has a 50 day moving average of $554.33 and a 200 day moving average of $532.98. The stock has a market capitalization of $176.40 billion, a price-to-earnings ratio of 77.27, a PEG ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00.

Insider Transactions at Intuitive Surgical

In related news, EVP Brian Edward Miller sold 8,900 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the sale, the executive vice president now directly owns 5,758 shares in the company, valued at $2,793,033.06. This trade represents a 60.72 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Robert Desantis sold 11,545 shares of the company’s stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the transaction, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. The trade was a 68.85 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 33,754 shares of company stock valued at $17,691,621 in the last quarter. 0.70% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on ISRG shares. Jefferies Financial Group increased their price objective on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $522.00 to $650.00 in a report on Monday, December 2nd. UBS Group increased their target price on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research note on Monday, January 27th. JPMorgan Chase & Co. boosted their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Finally, Stifel Nicolaus upped their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, December 5th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $611.86.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.